Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.
Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
Spanish National Hip Fracture Registry (RNFC): First-year results and comparison with other registries and prospective multi-centric studies from Spain].
Spanish National Hip Fracture Registry (RNFC): First-year results and comparison with other registries and prospective multi-centric studies from Spain].
Balancing benefits and risks in the era of biologics.
Balancing benefits and risks in the era of biologics.
Long term effects on biochemical bone markers of a single infusion of zoledronic acid in Paget disease of bone.
Long term effects on biochemical bone markers of a single infusion of zoledronic acid in Paget disease of bone.
Relationship between 1,25-Dihydroxyvitamin D and Body Composition in Middle-Aged Sedentary Adults: The FIT-AGEING Study. Nutrients
Relationship between 1,25-Dihydroxyvitamin D and Body Composition in Middle-Aged Sedentary Adults: The FIT-AGEING Study. Nutrients
Internistas del Hospital Macarena, premiados por la Sociedad Española de Investigación Ósea y Metabolismo
Un trabajo destaca que mediciones de densidad ósea en 3D permiten un tratamiento preventivo en pacientes con alto riesgo en fracturas
Internistas del Hospital Macarena de Sevilla, premiados por la Sociedad Española de Investigación Ósea y Metabolismo
Internistas del Hospital Macarena de Sevilla, premiados por la Sociedad Española de Investigación Ósea y Metabolismo Un trabajo destaca que mediciones de densidad ósea en 3D permiten un tratamiento preventivo en pacientes con alto riesgo … Leer más
